Tumor samples from 111 NSCLC patients treated with ICI monotherapy in first line (1L) or after one-or-more lines of chemotherapy (2L) (Supplementary Table 1) were evaluated for AXL expression by immunohistochemistry (IHC). This evidence concerns the gene AXL and neoplasm.